Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Poelaert

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
NPJ Systems Biology and Applications|November 28, 2024
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variantsRobert P Matson, Isin Y Comba, Eli Silvert, et al.
Cancers|April 3, 2021
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic CancerBrittany J Poelaert, Shelby M Knoche, Alaina C Larson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 26, 2020
Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastomaBrittany J Poelaert, Svetlana Romanova, Shelby M Knoche, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
NPJ Systems Biology and Applications|November 28, 2024
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variantsRobert P Matson, Isin Y Comba, Eli Silvert, et al.
Cancers|April 3, 2021
Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic CancerBrittany J Poelaert, Shelby M Knoche, Alaina C Larson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 26, 2020
Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastomaBrittany J Poelaert, Svetlana Romanova, Shelby M Knoche, et al.
Pageof 7